Thorne HealthTech, Inc.

NasdaqGS:THRN Stock Report

Market Cap: US$550.6m

Thorne HealthTech Past Earnings Performance

Past criteria checks 4/6

Thorne HealthTech has been growing earnings at an average annual rate of 121.9%, while the Personal Products industry saw earnings growing at 20.9% annually. Revenues have been growing at an average rate of 25.5% per year. Thorne HealthTech's return on equity is 12.7%, and it has net margins of 7.9%.

Key information

121.9%

Earnings growth rate

159.7%

EPS growth rate

Personal Products Industry Growth20.9%
Revenue growth rate25.5%
Return on equity12.7%
Net Margin7.9%
Last Earnings Update30 Jun 2023

Recent past performance updates

Recent updates

Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Aug 12
Results: Thorne HealthTech, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar

Jun 07
Thorne HealthTech, Inc. (NASDAQ:THRN) Not Flying Under The Radar

Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist

Dec 17
Investors Will Want Thorne HealthTech's (NASDAQ:THRN) Growth In ROCE To Persist

Thorne HealthTech Grows But Faces Macro Headwinds

Sep 09

Thorne HealthTech's blood collection device OneDraw gets clearance in Japan

Aug 23

Thorne HealthTech swings to Q2 Non-GAAP loss per share, revenue down Y/Y, FY22 guidance revised

Aug 09

Thorne HealthTech: Poised To Outperform Other Nutraceutical Companies

Jun 05

Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality

Mar 23
Shareholders Can Be Confident That Thorne HealthTech's (NASDAQ:THRN) Earnings Are High Quality

Thorne HealthTech: Good Potential At A Low Price

Jan 11

Revenue & Expenses Breakdown

How Thorne HealthTech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGS:THRN Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 23258201097
31 Mar 23240101117
31 Dec 22229161027
30 Sep 2221661027
30 Jun 2220631038
31 Mar 221949867
31 Dec 211844796
30 Sep 21172-1745
30 Jun 21162-1634
31 Mar 21150-3614
31 Dec 20138-3604
31 Dec 19103-22554

Quality Earnings: THRN has a high level of non-cash earnings.

Growing Profit Margin: THRN's current net profit margins (7.9%) are higher than last year (1.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: THRN's earnings have grown significantly by 121.9% per year over the past 5 years.

Accelerating Growth: THRN's earnings growth over the past year (548.7%) exceeds its 5-year average (121.9% per year).

Earnings vs Industry: THRN earnings growth over the past year (548.7%) exceeded the Personal Products industry -2.3%.


Return on Equity

High ROE: THRN's Return on Equity (12.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/10/18 03:10
End of Day Share Price 2023/10/13 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Thorne HealthTech, Inc. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Bryan SpillaneBofA Global Research
Susan AndersonCanaccord Genuity